Medicxi
Londonmedicxi.com
Overview
Medicxi is a European life sciences investment firm that specializes in drug discovery and therapeutic development by creating, investing in, and supporting biotech companies across the full drug development continuum.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Fore Biotherapeutics | Jul 2026 | Series D-2 Extension | Lead |
| Ethyreal Bio | Jun 2026 | Series B | Co-investor |
| Altesa BioSciences | Feb 2026 | Series B | Co-investor |
| Ethyreal Bio | Jan 2026 | Series B | Co-investor |
| D3 Bio | Dec 2025 | Series B | Co-investor |
Key People
Giuseppe Zocco
Co-Founder And Partner
Richard Lee
Co-Founder And Operating Partner
Benjamin Perry
Venture Partner
Charles Grummitt
Venture Partner
João Vieira
Venture Partner
Marco Prunotto
Venture Partner
Stephen Rapecki
Venture Partner
Thibaut De Smedt
Venture Partner
Giovanni Mariggi
Partner
Giovanni Pericolini
Partner And CFO
Shyam M.
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
